Joseph H Kado 21st Lancefield International Symposium for Streptococci and Streptococcal Diseases 2022

Abstracts this author is presenting:

• Subcutaneous infusions of high-dose benzathine penicillin G (SCIP) is safe, tolerable and potentially suitable for less frequent dosing for rheumatic heart disease secondary prophylaxis — Poster Session 1
• Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia — Parallel Session 14: Advances in rheumatic fever and rheumatic heart disease